Short Communication- Asian Journal of Pharmaceutical Technology and Innovation(2023)
Smart drug delivery systems and harnessing technology for targeted therapeutics.
Oscar Teutonico*Oscar Teutonico, Department of Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom, Email: saran.elena@lumc.nl
Received: 21-Mar-2023, Manuscript No. AJPTI-23-98698; Editor assigned: 28-Mar-2023, Pre QC No. AJPTI-23-98698 (PQ); Reviewed: 14-Apr-2023, QC No. AJPTI-23-98698; Revised: 21-Apr-2023, Manuscript No. AJPTI-23-98698 (R); Published: 28-Apr-2023
Description
Advancements in technology have revolutionized the field of medicine, particularly in drug delivery systems. Smart drug delivery systems employ innovative technologies to precisely target specific sites in the body, improving therapeutic outcomes while minimizing side effects. These systems combine pharmaceuticals with advanced materials, biosensors, and control mechanisms to ensure precise drug release, dose regulation, and personalized treatment. Harnessing technology for targeted therapeutics offers immense potential for enhancing drug efficacy, reducing toxicity, and improving patient compliance. In this, we will discuss the concept of smart drug delivery systems and discuss how technology is being harnessed to enable targeted therapeutics [1].
Smart drug delivery systems are designed to overcome the limitations of conventional drug delivery methods. They offer precise control over drug release, enabling therapeutic agents to reach their intended targets more effectively [2]. These systems employ various technologies, including nanotechnology, microfabrication, and biocompatible polymers, to encapsulate drugs and deliver them to specific sites in the body [3].
Nanotechnology plays a pivotal role in smart drug delivery systems. Nanoparticles, such as liposomes, polymeric nanoparticles, and carbon nanotubes, are commonly used as carriers for drugs [4]. These nanoparticles can be engineered to release drugs in response to specific triggers, such as pH, temperature, enzymes, or light. This allows drugs to be released at the target site, minimizing off- target effects and improving drug efficacy [5].
Microfabrication techniques enable the development of micro devices that can precisely control drug release. These devices can be implanted or injected into the body and programmed to release drugs at predetermined rates and intervals. They can also incorporate sensors to monitor physiological parameters and adjust drug release accordingly, ensuring optimal therapeutic outcomes [6].
Biocompatible polymers, such as hydrogels and micelles, provide another avenue for smart drug delivery. These polymers can encapsulate drugs and release them in response to external stimuli or physiological conditions. By modifying the polymer structure, researchers can tune the release rate and target specific tissues or cells, allowing for localized and sustained drug delivery [7].
Technology has revolutionized targeted therapeutics by providing innovative tools for precise drug delivery and personalized treatment. Here are some key areas where technology is being harnessed to enhance targeted therapeutics.
Advanced imaging techniques, such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET), enable accurate diagnosis and identification of disease sites. These imaging modalities can be coupled with drug delivery systems to guide and monitor the distribution of therapeutic agents in real-time. This integration allows for personalized treatment planning and adjustments based on individual patient responses [8].
Biosensors and wearable devices provide real-time monitoring of physiological parameters, biomarkers, and drug concentrations. By incorporating sensors into drug delivery systems, clinicians can gather valuable data to optimize treatment strategies. For example, sensors can detect changes in glucose levels for diabetic patients and trigger insulin release from a smart insulin pump, ensuring precise dosage and timing [9].
Functionalized nanoparticles and liposomes can be conjugated with targeting ligands, such as antibodies or peptides, to selectively bind to specific receptors on diseased cells. This targeted approach improves drug accumulation at the site of action, reducing systemic toxicity and enhancing therapeutic efficacy. Moreover, ligand- receptor interactions can facilitate active cellular uptake of drugs, overcoming barriers to drug delivery [10].
Conclusion
Smart drug delivery systems and the harnessing of technology for targeted therapeutics represent a significant advancement in the field of medicine. These innovative approaches offer precise control over drug release, enabling personalized treatment strategies and improved therapeutic outcomes. By incorporating nanotechnology, microfabrication, biosensors, and targeting ligands, these systems can deliver drugs to specific sites in the body, minimizing side effects and maximizing efficacy. Furthermore, the integration of imaging and diagnostic tools, sensor technology, and stimulus-responsive systems provides real-time monitoring and adjustments, optimizing treatment strategies for individual patients. As technology continues to advance, the potential for smart drug delivery systems to revolutionize healthcare and improve patient outcomes is truly promising.
References
- Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Nanotechnol Biol Med 8(2): 147-166.
- Mitchell MJ (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20(2): 101-124.
- Biondi M, Ungaro F, Quaglia F, Netti PA (2008) Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 60(2): 229-242.
- Karuppusamy C, Venkatesan P (2017) Role of nanoparticles in drug delivery system: a comprehensive review. J Pharm Sci 9(3): 318.
- Rafal B, Sikorski AF (2019) Editorial focus: understanding off-target effects as the key to successful RNAi therapy. Cell Mol Biol Lett 24(1): 1-23.
- Teymourian H, Parrilla M, Sempionatto JR, Montiel NF, Echelpoel RV et al. (2020) Wearable electrochemical sensors for the monitoring and screening of drugs. ACS Sens 5(9): 2679-2700.
- Singh R, James W (2009) Nanoparticle-based targeted drug delivery. Exp. Mol 86(3): 215-223.
- Chen W, Lu Y, Qiu L, Kumar S (2021) Designing personalized treatment plans for breast cancer. ISR 32(3): 932-949.
- Alsaleh FM, Smith FJ (2010) Insulin pumps: from inception to the present and toward the future. J Clin Pharm Ther 35(2): 127-138. .
- Zhang R, Qin X, Kong F, Chen P, Pan G (2019) Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Deliv 26(1): 328-342.
Citation: Teutonico O. Smart drug delivery systems and harnessing technology for targeted therapeutics AJPTI 2023;11(S41):1-2.